Literature DB >> 24512268

Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid Naringenin: design, characterization, in vitro and in vivo evaluation.

Abdul Wadood Khan1, Sabna Kotta, Shahid Husain Ansari, Rakesh Kumar Sharma, Javed Ali.   

Abstract

Naringenin (NRG), predominant flavanone in grapefruits, possesses anti-inflammatory, anti-carcinogenic, hepato-protective and anti-lipid peroxidation effects. Slow dissolution after oral ingestion due to its poor solubility in water, as well as low bioavailability following oral administration, restricts its therapeutic application. The study is an attempt to improve the solubility and bioavailability of NRG by employing self-nanoemulsifying drug delivery technique. Preliminary screening was carried out to select oil, surfactant and co-surfactant, based on solubilization and emulsification efficiency of the components. Pseudo ternary phase diagrams were constructed to identify the area of nanoemulsification. The developed self-nanoemulsifying drug delivery systems (SNEDDS) were evaluated in term of goluble size, globule size distribution, zeta potential, and surface morphology of nanoemulsions so obtained. The TEM analysis proves that nanoemulsion shows a droplet size less than 50 nm. Freeze thaw cycling and centrifugation studies were carried out to confirm the stability of the developed SNEDDS. In vitro drug release from SNEDDS was significantly higher (p < 0.005) than pure drug. Furthermore, area under the drug concentration time-curve (AUC(0-24)) of NRG from SNEDDS formulation revealed a significant increase (p < 0.005) in NRG absorption compared to NRG alone. The increase in drug release and bioavailability as compared to drug suspension from SNEDDS formulation may be attributed to the nanosized droplets and enhanced solubility of NRG in the SNEDDS.

Entities:  

Keywords:  Bioavailability; oil phase; pharmacokinetics; pseudoternary phase diagram; solubility

Mesh:

Substances:

Year:  2014        PMID: 24512268     DOI: 10.3109/10717544.2013.878003

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  30 in total

1.  Aerosolization Performance, Antitussive Effect and Local Toxicity of Naringenin-Hydroxypropyl-β-Cyclodextrin Inhalation Solution for Pulmonary Delivery.

Authors:  Minyi Guan; Xuan Zeng; Rui Shi; Yuying Zheng; Weiyang Fan; Weiwei Su
Journal:  AAPS PharmSciTech       Date:  2021-01-03       Impact factor: 3.246

2.  Improved antioxidant, antimicrobial and anticancer activity of naringenin on conjugation with pectin.

Authors:  Jyoti Mundlia; Munish Ahuja; Pradeep Kumar; Viness Pillay
Journal:  3 Biotech       Date:  2019-07-30       Impact factor: 2.406

Review 3.  Cancer prevention and therapy through the modulation of the tumor microenvironment.

Authors:  Stephanie C Casey; Amedeo Amedei; Katia Aquilano; Asfar S Azmi; Fabian Benencia; Dipita Bhakta; Alan E Bilsland; Chandra S Boosani; Sophie Chen; Maria Rosa Ciriolo; Sarah Crawford; Hiromasa Fujii; Alexandros G Georgakilas; Gunjan Guha; Dorota Halicka; William G Helferich; Petr Heneberg; Kanya Honoki; W Nicol Keith; Sid P Kerkar; Sulma I Mohammed; Elena Niccolai; Somaira Nowsheen; H P Vasantha Rupasinghe; Abbas Samadi; Neetu Singh; Wamidh H Talib; Vasundara Venkateswaran; Richard L Whelan; Xujuan Yang; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2015-04-10       Impact factor: 15.707

4.  The Potential Synergistic Activity of Zolmitriptan Combined in New Self-Nanoemulsifying Drug Delivery Systems: ATR-FTIR Real-Time Fast Dissolution Monitoring and Pharmacodynamic Assessment.

Authors:  Shady M Abd El-Halim; Mohamed A Mamdouh; Sherif M Eid; Bassant M M Ibrahim; Dina A Aly Labib; Sara M Soliman
Journal:  Int J Nanomedicine       Date:  2021-09-17

5.  Self-nanoemulsifying drug delivery system (SNEDDS) mediated improved oral bioavailability of thymoquinone: optimization, characterization, pharmacokinetic, and hepatotoxicity studies.

Authors:  Charul Rathore; Chetna Hemrajani; Abhishek Kumar Sharma; Piyush Kumar Gupta; Niraj Kumar Jha; Alaa A A Aljabali; Gaurav Gupta; Sachin Kumar Singh; Jen-Chang Yang; Ram Prakash Dwivedi; Kamal Dua; Dinesh Kumar Chellappan; Poonam Negi; Murtaza M Tambuwala
Journal:  Drug Deliv Transl Res       Date:  2022-07-13       Impact factor: 5.671

Review 6.  Investigating Polyphenol Nanoformulations for Therapeutic Targets against Diabetes Mellitus.

Authors:  Fahadul Islam; Jannatul Fardous Khadija; Md Rezaul Islam; Sheikh Shohag; Saikat Mitra; Saad Alghamdi; Ahmad O Babalghith; Abdulrahman Theyab; Mohammad Tauhidur Rahman; Aklima Akter; Abdullah Al Mamun; Fahad A Alhumaydhi; Talha Bin Emran
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-21       Impact factor: 2.650

7.  Development of Solid Self-Emulsifying Formulation for Improving the Oral Bioavailability of Erlotinib.

Authors:  Duy Hieu Truong; Tuan Hiep Tran; Thiruganesh Ramasamy; Ju Yeon Choi; Hee Hyun Lee; Cheol Moon; Han-Gon Choi; Chul Soon Yong; Jong Oh Kim
Journal:  AAPS PharmSciTech       Date:  2015-08-04       Impact factor: 3.246

8.  Self-Nanoemulsifying Drug Delivery System of Genkwanin: A Novel Approach for Anti-Colitis-Associated Colorectal Cancer.

Authors:  Hua-Feng Yin; Chun-Ming Yin; Ting Ouyang; Shu-Ding Sun; Wei-Guo Chen; Xiao-Lin Yang; Xin He; Chun-Feng Zhang
Journal:  Drug Des Devel Ther       Date:  2021-02-12       Impact factor: 4.162

9.  Custom fractional factorial designs to develop atorvastatin self-nanoemulsifying and nanosuspension delivery systems--enhancement of oral bioavailability.

Authors:  Fahima M Hashem; Majid M Al-Sawahli; Mohamed Nasr; Osama A A Ahmed
Journal:  Drug Des Devel Ther       Date:  2015-06-19       Impact factor: 4.162

10.  A novel self-nanoemulsifying drug delivery system for curcumin used in the treatment of wound healing and inflammation.

Authors:  Niyaz Ahmad; Rizwan Ahmad; Ali Al-Qudaihi; Salman Edrees Alaseel; Ibrahim Zuhair Fita; Mohammed Saifuddin Khalid; Faheem Hyder Pottoo; Srinivasa Rao Bolla
Journal:  3 Biotech       Date:  2019-09-09       Impact factor: 2.893

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.